Yes in the vicinity of that price too for a TO.
Great drug and great platform as mentioned in the webinar.
Looking to trend higher than the last 2 TO amounts, plus looking at sales in Japan and using a comparison I can see why that price per share is mentioned.
The potential worldwide access to come after FDA is very enticing too.
All in all it's looking promising except the last few weeks of consolidation, would have liked to have seen a break thru of the 30 wall.
Just need that final tick of approval
BOT - Anything but charting, page-8626
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
-0.010(2.41%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 42.5¢ | 39.5¢ | $3.680M | 8.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 297011 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 12027 | 3 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |